Clinical Trial Update: S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating S-1 or Tegafur-Uracil in patients with previously treated stage III or stage IV head and neck cancer. The current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)
• Tegafur-Uracil (tegafur-uracil)

Snippet

Sponsor: Yokohama City University | Conditions: Head and Neck Cancer | Phase 3 | Status: UNKNOWN